TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
ICON issues 2025 guidance, stock slides 8%
ICON ( NASDAQ: ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...
ICON Backs Annual Guidance, Initiates 2025 Outlook; Pre-Market Stock Down
ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the ...